methylprednisolone has been researched along with lycopene in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
El-Ashmawy, NE; El-Bahrawy, HA; Hamada, OB; Khedr, NF | 1 |
Bitto, A; Booz, C; D'Angelo, T; Giorgi, DA; Ieni, A; Irrera, N; Mannino, F; Mazziotti, S; Pallio, G; Pirrotta, I; Scarfone, A; Squadrito, F | 1 |
2 other study(ies) available for methylprednisolone and lycopene
Article | Year |
---|---|
Suppression of inducible nitric oxide synthase and tumor necrosis factor-alpha level by lycopene is comparable to methylprednisolone in acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Anti-Inflammatory Agents; Antioxidants; Carotenoids; Disease Models, Animal; Gene Expression; Lycopene; Male; Methylprednisolone; Nitric Oxide Synthase Type II; Oxidative Stress; Pancreas; Pancreatitis; Peroxidase; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2018 |
The Nutraceutical Genistein-Lycopene Combination Improves Bone Damage Induced by Glucocorticoids by Stimulating the Osteoblast Formation Process.
Topics: Alendronate; Animals; Antioxidants; beta Catenin; Bone Density; Core Binding Factor Alpha 1 Subunit; Dexamethasone; Dietary Supplements; Genistein; Glucocorticoids; Lycopene; Methylprednisolone; Osteoblasts; Osteogenesis; Osteoporosis | 2022 |